Cardiovascular , noncardiovascular , and uncategorizable deaths for TF-TAVR were 37 % , 43 % , and 20 % , respectively , versus 22 % , 41 % , and 37 % , respectively , for TA-TAVR and 33 % , 43 % , and 24 % , respectively , for AVR .